iPSC Culture and Differentiation

Inactive on SAM.gov — responses were due 12 Nov 2026 · No Set aside used · National Institutes of Health (NIH), HHS · Bethesda, MD · NAICS 325414 · Solicitation 75N98027Q00053

Following NAICS 325414? Get new solicitations in it by email as they post — no account needed.

Email me new ones

What happened next

SAM.gov marked this notice inactive — responses were due 12 November 2026.

No award notice on SAM.gov yet. Not every award is posted there, so this does not mean it went unawarded.

Email me when the award is announced. One email, when SAM.gov posts the award notice. Not every award is posted there; if none appears within six months we'll tell you and stop. No account needed.

Solicitation details

Solicitation number75N98027Q00053
Notice ID02d13f335316488bae3480944a2232a2
AgencyDepartment of Health and Human Services (HHS)
Sub-agencyNational Institutes of Health (NIH)
Contracting officeNATIONAL INSTITUTES OF HEALTH OLAO
NAICS code325414 — Biological Product (Except Diagnostic) Manufacturing
Product / service code (PSC)Q301
Set-asideNo Set aside used
Notice typePresolicitation
Posted03 November 2026
Response deadline12 November 2026 (closed)
Place of performanceBethesda, MD, USA
CompetitionLikely sole source (FedSift estimate from the notice text) — confirm on SAM.gov before investing in a bid

Get new NAICS 325414 solicitations by email

This one has closed. We'll email you when new NAICS 325414 (Biological Product (Except Diagnostic) Manufacturing) solicitations post — the first email lists what is open right now, then at most once a week, only when something new posts. No account needed; unsubscribe in a click.

Description

NOTICE OF INTENT – SOLE-SOURCE ACQUISITION Notice No.: The National Institutes of Health (NIH), National Institute of Environmental Health Sciences (NIEHS), intends to award a Firm-Fixed-Price Purchase Order to Creative Biolab Inc. for culture all cells and differentiate them, expand their cell populations to more than 20 million, collect them, verify cell count, and send them back to us. Description of the Requirement The primary objective of this study is to sequence and analyze the 4q35 locus on Chromosome 4 for several years. This locus is a gene-poor and extremely long (>100K) region of DNA that consists of many repetitive sequences which makes sequencing and analysis extremely difficult. To sequence this locus using Nanopore Sequencing technology. To expand the number of samples for our experiment, we looked for a company that can handle numerous cell lines and follow the protocol that we provide. Creative Biolabs is the only company/research institute that has been able to perform differentiation within 3 months and has the ability to follow our protocol with numerous cell lines. Justification for the Proposed Sole-Source Acquisition The Government intends to solicit from a single source pursuant to FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements. Only Creative Biolabs was willing to follow our exact protocol and had the logistical capacity to handle the large number of cell lines that we need to analyze, which is vital to research at the National Institute of Environmental Health Sciences. Response Information This notice is not a request for competitive quotations or proposals. However, interested parties that believe they can meet the Government's requirements may submit a capability statement demonstrating their ability to provide the required preventive maintenance and remedial repair services for the specified instrument and meet all applicable technical and operational requirements. The Government will review timely submissions to determine whether another responsible source is capable of satisfying the requirement and whether a competitive acquisition is appropriate. The Government anticipates making an award approximately five (5) calendar days after the closing date of this notice, unless the Government determines that another responsible source can satisfy the requirement. Capability statements must be submitted electronically to verne.griffin@nih.gov no later than 9:00 a.m. EDT on November 13, 2026. Please reference Notice No. 75N98027Q00053 in the subject line of the submission.

Go deeper on this solicitation

FedSift reads the full solicitation package — every attachment — and pre-extracts the compliance matrix, evaluation factors, key risks, win themes and deal-breakers, each with a verbatim quote and the exact PDF page it came from. It scores the opportunity against your company profile, tells you whether to bid as prime or sub, and ranks teaming partners who could close your gaps.

Open the AI analysis in FedSift →

Free forever plan — no credit card. Browse solicitations without an account; sign in for AI analysis and matching.

Market context: HHS and NAICS 325414

About the buyer and the industry, not this specific solicitation. Source: USASpending.gov award data, updated nightly.

  • In fiscal year 2026, HHS obligated $51.7M across 51 contract actions under NAICS 325414.
  • 27 contracts worth $874.1M in this category end within the next 18 months.

HHS contracts under NAICS 325414 →

Other open solicitations in NAICS 325414

All NAICS 325414 solicitations →

More from Department of Health and Human Services

All HHS solicitations →

Source: this notice on SAM.gov. FedSift republishes public federal procurement data and is not affiliated with the U.S. Government. Always confirm dates and requirements against SAM.gov before responding.

FedSift turns SAM.gov and USASpending data into federal BD intelligence — smart matches, recompete radar, cited AI solicitation analysis and compliance matrices.

Source data: SAM.gov (solicitations) and USASpending.gov (awards), refreshed nightly. FedSift is not affiliated with the U.S. Government.

Pricing · Privacy · Terms · support@fedsift.app